These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 18693545)

  • 1. [Intrasal corticosteriods prescription to allergic rhinoconjunctivitis and rhinosinusitis during pediatric ages].
    Sacre Hazouri JA; de la Torre González C; López González AL; Alvarez Vega R
    Rev Alerg Mex; 2007; 54(6):205-12. PubMed ID: 18693545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Should intranasal corticosteroids be used for the treatment of ocular symptoms of allergic rhinoconjunctivitis? A review of their efficacy and safety profile.
    Lightman S; Scadding GK
    Int Arch Allergy Immunol; 2012; 158(4):317-25. PubMed ID: 22488416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic options for reducing sleep impairment in allergic rhinitis, rhinosinusitis, and nasal polyposis.
    Storms W; Yawn B; Fromer L
    Curr Med Res Opin; 2007 Sep; 23(9):2135-46. PubMed ID: 17666161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Seasonal and Perennial Allergic Rhinoconjunctivitis].
    Schröder K; Finis D; Meller S; Buhren BA; Wagenmann M; Geerling G
    Laryngorhinootologie; 2017 Feb; 96(2):89-97. PubMed ID: 28291999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and management of undiagnosed and undertreated allergic rhinitis in adults and children.
    Stewart MG
    Clin Exp Allergy; 2008 May; 38(5):751-60. PubMed ID: 18419620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How do topical nasal corticosteroids improve sleep and daytime somnolence in allergic rhinitis?
    Craig TJ; Hanks CD; Fisher LH
    J Allergy Clin Immunol; 2005 Dec; 116(6):1264-6. PubMed ID: 16337455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The comparison of the efficacy and safety of cetirizine, oxatomide, ketotifen, and a placebo for the treatment of childhood perennial allergic rhinitis.
    Lai DS; Lue KH; Hsieh JC; Lin KL; Lee HS
    Ann Allergy Asthma Immunol; 2002 Dec; 89(6):589-98. PubMed ID: 12487225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal corticosteroids and allergic rhinoconjunctivitis.
    Origlieri C; Bielory L
    Curr Opin Allergy Clin Immunol; 2008 Oct; 8(5):450-6. PubMed ID: 18769200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of topical nasal azelastine on the symptoms of rhinitis, sleep, and daytime somnolence in perennial allergic rhinitis.
    Golden S; Teets SJ; Lehman EB; Mauger EA; Chinchilli V; Berlin JM; Kakumanu S; Lucus T; Craig TJ
    Ann Allergy Asthma Immunol; 2000 Jul; 85(1):53-7. PubMed ID: 10923605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sleep impairment and daytime sleepiness in patients with allergic rhinitis: the role of congestion and inflammation.
    Thompson A; Sardana N; Craig TJ
    Ann Allergy Asthma Immunol; 2013 Dec; 111(6):446-51. PubMed ID: 24267356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost efficiency of intranasal corticosteroid prescribing patterns in the management of allergic rhinitis.
    Reissman D; Price T; Leibman CW
    J Manag Care Pharm; 2004 Jan; 10(1 Suppl):S9-13. PubMed ID: 14720101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sleep impairment in allergic rhinitis, rhinosinusitis, and nasal polyposis.
    Craig TJ; Ferguson BJ; Krouse JH
    Am J Otolaryngol; 2008; 29(3):209-17. PubMed ID: 18439959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocorticosteroids in allergic inflammation: clinical benefits in allergic rhinitis, rhinosinusitis, and otitis media.
    van Cauwenberge P; Van Hoecke H; Vandenbulcke L; Van Zele T; Bachert C
    Immunol Allergy Clin North Am; 2005 Aug; 25(3):489-509, vi. PubMed ID: 16054539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levocabastine: a new topical approach for the treatment of paediatric allergic rhinoconjunctivitis.
    Janssens MM
    Rhinol Suppl; 1992 Sep; 13():39-49. PubMed ID: 1358140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcomes and adverse effect monitoring in allergic rhinitis.
    Juniper EF; Ståhl E; Doty RL; Simons FE; Allen DB; Howarth PH
    J Allergy Clin Immunol; 2005 Mar; 115(3 Suppl 1):S390-413. PubMed ID: 15746880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of bilastine upon the ocular symptoms of allergic rhinoconjunctivitis.
    Bartra J; Mullol J; Montoro J; Jáuregui I; del Cuvillos A; Dávila I; Ferrer M; Sastre J; Valero A
    J Investig Allergol Clin Immunol; 2011; 21 Suppl 3():24-33. PubMed ID: 22185047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The problem of placebo-controlled trials allowing rescue medication: how to assess efficacy in rhinosinusitis and allergic rhinoconjunctivitis when both groups receive active rescue treatment.
    Vent J; Lehmacher W
    Curr Opin Allergy Clin Immunol; 2009 Jun; 9(3):222-7. PubMed ID: 19454884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allergic rhinitis and its effect on sleep, fatigue, and daytime somnolence.
    Santos CB; Pratt EL; Hanks C; McCann J; Craig TJ
    Ann Allergy Asthma Immunol; 2006 Nov; 97(5):579-86; quiz 586-9, 671. PubMed ID: 17165263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal corticosteroids reduce ocular symptoms associated with allergic rhinitis.
    Naclerio R
    Otolaryngol Head Neck Surg; 2008 Feb; 138(2):129-39. PubMed ID: 18241703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihistamines in rhinoconjunctivitis.
    Howarth P
    Clin Allergy Immunol; 2002; 17():179-220. PubMed ID: 12113217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.